Skip to main content
. 2015 Feb 18;14:9. doi: 10.1186/s12944-015-0005-6

Table 5.

Analysis of FA in triglyceride and phospholipid fractions

(a) Triglyceride (b) Phospholipid
Fatty acid Vehicle OO SO FO Fatty acid Vehicle OO SO FO
C8:0 0.14 ± 0.05a 0.06 ± 0.00b 0.15 ± 0.08a 0.10 ± 0.04a C8:0 0.13 ± 0.04a 0.04 ± 0.00b 0.11 ± 0.03a 0.16 ± 0.05a
C10:0 0.05 ± 0.01a 0.03 ± 0.01a 0.09 ± 0.01a 0.06 ± 0.03a C10:0 0.07 ± 0.01a 0.03 ± 0.00a 0.05 ± 0.01a 0.10 ± 0.05a
C12:0 0.14 ± 0.02a 0.07 ± 0.02b 0.21 ± 0.08a 0.03 ± 0.01b C12:0 0.15 ± 0.06a 0.04 ± 0.01b 0.06 ± 0.00b 0.05 ± 0.04b
C14:0 0.42 ± 0.04a 0.41 ± 0.05a 0.42 ± 0.02a 0.81 ± 0.07b C14:0 3.36 ± 0.30a 0.62 ± 0.25b 0.82 ± 0.10b 0.92 ± 0.37b
C16:0 1.19 ± 0.42a 12.98 ± 1.67b 8.06 ± 0.92c 12.92 ± 1.74b C16:0 25.93 ± 1.65a 14.41 ± 1.74b 17.97 ± 1.83b 11.15 ± 1.60b
C16:1n7 0.17 ± 0.06a 0.67 ± 0.07b 0.33 ± 0.03c 0.48 ± 0.08d C16:1n7 3.69 ± 0.20a 0.72 ± 0.02b 0.72 ± 0.10b 0.43 ± 0.05c
C18:0 0.54 ± 0.15a 3.47 ± 0.42b 2.97 ± 0.30b 3.24 ± 0.39b C18:0 15.79 ± 0.70a 7.43 ± 1.51b 10.93 ± 1.01b 5.99 ± 1.40b
C18:1n-9 0.85 ± 0.32a 19.41 ± 2.31b 8.50 ± 0.91c 22.12 ± 3.65b C18:1n-9 20.82 ± 1.09a 11.56 ± 1.14b 12.22 ± 1.30b 10.26 ± 2.78b
C18:1 n-7 0.19 ± 0.07a 1.05 ± 0.24b 0.51 ± 0.06c 1.17 ± 0.17b C18:1 n-7 8.16 ± 0.40a 1.69 ± 0.12b 1.92 ± 0.21b 1.21 ± 0.18b
C18:2n-6 0.70 ± 0.99a 6.07 ± 0.82b 7.54 ± 1.01b 7.53 ± 1.31b C18:2n-6 1.39 ± 0.05a 4.19 ± 0.51b 6.66 ± 0.69c 2.98 ± 0.54b
C18:3n-3 N/D 0.98 ± 0.17a 0.51 ± 0.06b 0.17 ± 0.03c C18:3n-3 0.15 ± 0.02a 0.32 ± 0.04b 0.31 ± 0.04b 0.11 ± 0.03a
C18:3n-6 N/D N/D 0.29 ± 0.05a 0.08 ± 0.01b C18:3n-6 0.05 ± 0.02a 0.04 ± 0.01a 0.08 ± 0.02a 0.03 ± 0.01a
C20:0 N/D N/D N/D N/D C20:0 0.10 ± 0.00a 0.05 ± 0.02b 0.05 ± 0.02b 0.06 ± 0.02b
C20:4n-6 N/D 4.02 ± 0.49a 3.80 ± 0.51a 4.96 ± 0.76a C20:4n-6 9.74 ± 0.16a 4.75 ± 0.43b 7.00 ± 0.82c 3.54 ± 0.59b
C20:5n-3 N/D N/D 0.15 ± 0.02a 2.45 ± 0.40b C20:5n-3 0.12 ± 0.01a 0.06 ± 0.01b 0.14 ± 0.04a 0.66 ± 0.09c
C22:0 0.13 ± 0.02 N/D N/D N/D C22:0 0.22 ± 0.03a 0.19 ± 0.13a 0.12 ± 0.02b 0.11 ± 0.02b
C22:5n-6 N/D 0.45 ± 0.07a 0.25 ± 0.01b 0.78 ± 0.15a C22:5n-6 1.28 ± 0.03a 0.71 ± 0.04b 0.70 ± 0.08b 0.44 ± 0.06c
C22:5n-3 N/D 0.20 ± 0.03a 0.35 ± 0.05b 0.82 ± 0.32c C22:5n-3 1.62 ± 0.04a 0.35 ± 0.02b 0.71 ± 0.09c 0.32 ± 0.06b
C24:0 N/D N/D N/D N/D C24:0 0.30 ± 0.03a 0.07 ± 0.01b 0.12 ± 0.01c 0.08 ± 0.01b
C22:6n-3 N/D 1.28 ± 0.17a 2.00 ± 0.31a,b 2.82 ± 0.54b,c C22:6n-3 2.26 ± 0.07a 1.60 ± 0.14b 3.18 ± 0.31a 0.84 ± 0.24c
SFA 2.60 ± 0.72a 17.01 ± 2.17b 11.90 ± 1.41c 17.16 ± 2.27b SFA 46.05 ± 2.82a 22.88 ± 3.66b 30.21 ± 3.04c 18.64 ± 3.57b
MUFA 1.21 ± 0.46a 21.13 ± 2.62b 9.34 ± 1.00c 23.77 ± 3.90b MUFA 32.67 ± 1.69a 13.9 ± 61.28b 14.86 ± 1.61b 11.90 ± 3.01b
n-6 PUFA 0.70 ± 0.99a 10.55 ± 1.39b 11.88 ± 1.57b 13.35 ± 2.24b n-6 PUFA 12.45 ± 0.25a 9.68 ± 0.98b 14.44 ± 1.60a 6.99 ± 1.20c
n-3 PUFA N/D 2.45 ± 0.37a 3.01 ± 0.43a 6.27 ± 1.28b n-3 PUFA 4.15 ± 0.15a 2.33 ± 0.20b 4.35 ± 0.47a 1.92 ± 0.42b
TOTAL 4.52 ± 2.18a 51.14 ± 6.54b 36.14 ± 4.42c 60.55 ± 9.69b TOTAL 95.32 ± 4.91a 48.86 ± 6.12b 63.86 ± 6.72c 39.45 ± 8.20b

HAECs were supplemented with lipid emulsions (1%) for 24 hours under standard tissue culture conditions prior to analysis. Triglycerides (a) and Phospholipids (b) were resolved using thin layer chromatography and extracted as described in the methods. An “ND” indicates the lack of fatty acid detection. Results are expressed as the mean (wt%) ± SD of three experiments. One-way ANOVA with Tukey’s post hoc test using SPSS Statistics 20 software was performed to test differences between groups. The numbers with different letters represent a statistically significant difference p < 0.05.